Endpoints News 生物医药· Alex Hoffman·· 2026-10-02AI 评分21
Moderna 与 Neurocrine 迎回老将,Pharming CEO 因与董事会分歧离任
Moderna, Neurocrine bring back familiar faces; Pharming CEO exits after clashing with board
AI 导读
Juan Andres 将于 10 月 5 日结束退休,重新出任 Moderna 首席运营官(COO)。Pharming 首席执行官因与董事会产生分歧而退出。这两家公司的人事变动涉及高管回归及 CEO 离任。
正文
→ Juan Andres will come out of retirement to rejoin Moderna as COO on Oct. 5, bringing his intimate knowledge of the company as its …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news